Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
20 studies found for:    Open Studies | "Rickets"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Rickets"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition: Autosomal Dominant Hypophosphatemic Rickets
Intervention: Dietary Supplement: Iron
2 Unknown  Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Condition: Hypophosphatemic Rickets, X-Linked Dominant
Intervention: Drug: Cinacalcet
3 Recruiting A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
Condition: X-linked Hypophosphatemic Rickets/Osteomalacia
Intervention: Drug: KRN23
4 Recruiting Calcitonin for Treating X-linked Hypophosphatemia
Condition: Hypophosphatemic Rickets, X Linked Dominant
Interventions: Drug: nasal salmon calcitonin;   Drug: Saline Nasal Spray Placebo
5 Unknown  Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Hypovitaminosis D;   Hypomagnesemia;   Hyperparathyroidism
Intervention:
6 Recruiting Resistance to Vitamin D or Parathyroid Hormone
Conditions: Hypocalcemia;   Pseudohypoparathyroidism;   Albright Hereditary Osteodystrophy;   Rickets
Intervention:
7 Not yet recruiting Vitamin D, Iodine, and Lead Levels in Haitian Infants and Children.
Conditions: Vitamin D Deficiency;   Iodine Deficiency;   Hypothyroidism;   Rickets;   Lead Intoxication
Intervention:
8 Recruiting Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Condition: Osteomalacia
Intervention: Drug: Osteomalacia
9 Not yet recruiting Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Intervention: Drug: KRN23
10 Unknown  Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity
Conditions: Diabetes Mellitus Type 2;   Hypovitaminosis D
Interventions: Drug: Cholecalciferol;   Other: Orange juice
11 Not yet recruiting Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients
Condition: Hypovitaminosis D
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
12 Recruiting Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
Conditions: Chronic Renal Insufficiency;   Renal Osteodystrophy
Intervention:
13 Recruiting Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia
Condition: Tumor Induced Oncogenic Osteomalacia
Intervention:
14 Unknown  Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
Conditions: Chronic Kidney Disease;   Renal Osteodystrophy;   Left Ventricular Hypertrophy
Intervention:
15 Recruiting 68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia
Conditions: Oncogenic Osteomalacia;   Mesenchymal Tumor
Intervention: Drug: 68Ga-DOTATATE
16 Unknown  Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
Conditions: Renal Insufficiency, Chronic;   Renal Osteodystrophy
Interventions: Drug: Yougui granules;   Drug: Zuogui granules;   Drug: Yougui granules placebo;   Drug: Zuogui granules placebo
17 Not yet recruiting Study of KRN23 in Adult Subjects With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Conditions: Tumor Induced Osteomalacia (TIO);   Epidermal Nevus Syndrome (ENS)
Intervention: Drug: KRN23
18 Recruiting Renal Osteodystrophy: A Fresh Approach
Condition: Renal Osteodystrophy
Intervention:
19 Recruiting Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)
Condition: Hypophosphatasia
Intervention: Drug: asfotase alfa
20 Recruiting Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function
Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D;   Drug: 25(OH)D3

Indicates status has not been verified in more than two years